Back to search

Article

SCA44- and SCAR13-associated <i>GRM1</i> mutations affect metabotropic glutamate receptor 1 function through distinct mechanisms

2023-07-05

Abstract excerpt

Metabotropic glutamate receptor 1 (mGlu 1 ) is a promising therapeutic target for neurodegenerative CNS disorders including spinocerebellar ataxias (SCAs). Clinical reports have identified naturally-occurring mGlu 1 mutations in rare SCA subtypes and clinical symptoms of mGlu 1 mutations have been described. However, how mutations alter mGlu 1 function remains unknown. We explored SCA-associated mutation effec...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f63f9704-7bfe-55d8-9064-0504f444a175
DOI
10.1101/2023.07.05.545810
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
SCA44- and SCAR13-associated <i>GRM1</i> mutations affect metabotropic glutamate receptor 1 function through distinct mechanismsDOI 10.1101/2023.07.05.545810
Select a neighboring publication to make it the new centre.